Evaluation of Quality of Life and Organ Function in Head and Neck Squamous Cell Carcinoma

Hematology/Oncology Clinics of North America

Volumn 22, Issue 6, 2008, Pages 1239-1256

  Martino, Rosemary ^a,b   Ringash, Jolie ^a,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Head and neck cancer; Measurement outcomes; Quality of life; Speech; Swallowing; Xerostomia

Indexed keywords

AMIFOSTINE;

CLINICAL EVALUATION; DISEASE ASSOCIATION; DYSPHAGIA; HEAD AND NECK CANCER; HUMAN; INTENSITY MODULATED RADIATION THERAPY; OUTCOME ASSESSMENT; PATIENT CARE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SPEECH DISORDER; SQUAMOUS CELL CARCINOMA; XEROSTOMIA;

CANADA; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; HEAD AND NECK NEOPLASMS; HUMANS; QUALITY OF LIFE; TIME FACTORS;

EID: 55849152115     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hoc.2008.08.011     Document Type: Review

References (118)

1. Canadian Cancer Society/National Cancer Institute of Canada. Canadian cancer statistics 2007 (2007), Canadian Cancer Society, Toronto
2. Bernier J. A multidisciplinary approach to squamous cell carcinomas of the head and neck: an update. Curr Opin Oncol 20 3 (2008) 249-255
3. Semrau R., Mueller R.P., Stuetzer H., et al. Efficacy of intensified hyperfractionated and accelerated radiotherapy and concurrent chemotherapy with carboplatin and 5-fluorouracil: updated results of a randomized multicentric trial in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 64 5 (2006) 1308-1316
4. National Cancer Institute. Availabe at:. http://www.cancer.gov Accessed June 30, 2008
5. Pignon J.P., le Maitre A., and Bourhis J. Meta-analyses of chemotherapy in head and neck cancer (mach-nc): an update. Int J Radiat Oncol Biol Phys 69 2 Suppl (2007) S112-S114
6. Bonner J.A., Harari P.M., Giralt J., et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 354 6 (2006) 567-578
7. Trotti A., Pajak T.F., Gwede C.K., et al. TAME: development of a new method for summarizing adverse events of cancer treatment by the Radiation Therapy Oncology Group. Lancet Oncol 8 7 (2007) 613-624
8. Rogers S.N., Ahad S.A., and Murphy A.P. A structured review and theme analysis of papers published on 'quality of life' in head and neck cancer: 2000-2005. Oral Oncol 43 9 (2007) 843-868
9. Lipscomb J., Gotay C.C., and Snyder C.F. Patient-reported outcomes in cancer: a review of recent research and policy initiatives. CA Cancer J Clin 57 5 (2007) 278-300
10. Lipscomb J., Reeve B.B., Clauser S.B., et al. Patient-reported outcomes assessment in cancer trials: taking stock, moving forward. J Clin Oncol 25 32 (2007) 5133-5140
11. Murphy B.A., Ridner S.H., Wells N., et al. Quality of life research in head and neck cancer: a review of the current state of the science. Crit Rev Oncol Hematol 62 3 (2007) 251-267
12. Chaturvedi S.K., Shenoy A., Prasad K.M., et al. Concerns, coping and quality of life in head and neck cancer patients. Support Care Cancer 4 3 (1996) 186-190
13. Curran D., Giralt J., Harari P.M., et al. Quality of life in head and neck cancer patients after treatment with high-dose radiotherapy alone or in combination with cetuximab. J Clin Oncol 25 16 (2007) 2191-2197
14. Murphy B.A., Gilbert J., Cmelak A., et al. Symptom control issues and supportive care of patients with head and neck cancers. Clin Adv Hematol Oncol 5 10 (2007) 807-822
15. Glover J.A. The incidence of tonsillectomy in school children. Proc R Soc Med 31 (1938) 1219-1236
16. Eddy D. Variations in physician practice: the role of uncertainty. Health Aff 3 (1984) 75-89
17. Wennberg J. Dealing with medical practice variations: a proposal for action. Health Aff 7 (1988) 7-32
18. Relman A.S. Assessment and accountability: the third revolution in medical care. N Engl J Med 319 18 (1988) 1220-1222
19. Ellwood P.M. Shattuck lecture-outcomes management. A technology of patient experience. N Engl J Med 318 23 (1988) 1549-1556
20. McHorney C.A. Ten recommendations for advancing patient-centered outcomes measurement for older persons. Ann Intern Med 139 5 Pt 2 (2003) 403-409
21. McDowell I., and Jenkinson C. Development standards for health measures. J Health Serv Res Policy 1 4 (1996) 238-246
22. Long A.F., and Dixon P. Monitoring outcomes in routine practice: defining appropriate measurement criteria. J Eval Clin Pract 2 1 (1996) 71-78
23. McHorney C.A. Health status assessment methods for adults: past accomplishments and future challenges. Annu Rev Public Health 20 (1999) 309-335
24. Cleary P.D. Future directions of quality of life research. In: Spilker B. (Ed). Quality of life and pharmacoeconomics in clinical trials (1996), Lippincott-Raven Publishers, Philadelphia 73-78
25. Wilson I.B., and Cleary P.D. Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. JAMA 273 1 (1995) 59-65
26. Wood-Dauphinee S. Assessing quality of life in clinical research: from where have we come and where are we going?. J Clin Epidemiol 52 4 (1999) 355-363
27. McDowell I., and Newell C. Measuring health: a guide to rating scales and questionnaires (1996), Oxford University Press, Toronto
28. Gill T.M., and Feinstein A.R. A critical appraisal of the quality of quality-of-life measurements. JAMA 272 8 (1994) 619-626
29. Andresen E.M., Lollar D.J., and Meyers A.R. Disability outcomes research: why this supplement, on this topic, at this time?. Arch Phys Med Rehabil 81 12 Suppl 2 (2000) S1-S4
30. Gray D.B., and Hendershot G.E. The ICIDH-2: developments for a new era of outcomes research. Arch Phys Med Rehabil 81 12 Suppl 2 (2000) S10-S14
31. World Health Organization. International classification of impairments, activities and participation: a manual of dimensions of disablement and functioning (1997), World Health Organization, Geneva
32. Meyers A.R., Andresen E.M., and Hagglund K.J. A model of outcomes research: spinal cord injury. Arch Phys Med Rehabil 81 12 Suppl 2 (2000) S81-S90
33. Bombardier C., and Tugwell P. Methodological considerations in functional assessment. J Rheumatol 14 Suppl 15 (1987) 6-10
34. Guyatt G.H., Kirshner B., and Jaeschke R. Measuring health status: what are the necessary measurement properties?. J Clin Epidemiol 45 12 (1992) 1341-1345
35. Feinstein A.R. Chapter 2: Nomenclature and functional classification of clinimetric indexes. Clinemetrics (1987), Yale University Press, New Haven (CT) p. 6-21
36. Kane R.A., and Kane R.L. Assessing the elderly: a practical guide to measurement (1981), Lexington Books, Toronto
37. Kirshner B., and Guyatt G. A methodological framework for assessing health indices. J Chronic Dis 38 1 (1985) 27-36
38. Williams J.I., and Naylor C.D. How should health status measures be assessed? Cautionary notes on procrustean frameworks. J Clin Epidemiol 45 12 (1992) 1347-1351
39. McHorney C.A., and Tarlov A.R. Individual-patient monitoring in clinical practice: are available health status surveys adequate?. Quality of Life Research 4 4 (1995) 293-307
40. Nunnally J.C., and Bernstein I.H. Psychometric theory (1994), McGraw-Hill, Inc., Toronto
41. Streiner D.L., and Norman G.R. Health measurement scales: a practical guide to their development and use (1995), Oxford University Press, New York
42. McHorney C.A. Generic health measurement: past accomplishments and a measurement paradigm for the 21st century. Ann Intern Med 127 8 Pt 2 (1997) 743-750
43. Wright J.G., and Feinstein A.R. A comparative contrast of clinimetric and psychometric methods for constructing indexes and rating scales. J Clin Epidemiol 45 11 (1992) 1201-1218
44. Marx R.G., Bombardier C., Hogg-Johnson S., et al. Clinimetric and psychometric strategies for development of a health measurement scale. J Clin Epidemiol 52 2 (1999) 105-111
45. Chambers L.W., Macdonald L.A., Tugwell P., et al. The McMaster Health index questionnaire as a measure of quality of life for patients with rheumatoid disease. J Rheumatol 9 5 (1982) 780-784
46. Feinstein A.R. Clinimetrics (1987), Yale University Press, New Haven (CT)
47. Meyer G.J. Guidelines for reporting information in studies of diagnostic test accuracy: the Stard initiative. J Pers Assess 81 3 (2003) 191-193
48. Streiner D.L., and Norman G.R. Health measurement scales: a practical guide to their development and use (2003), Oxford University Press, New York
49. World Health Organization. Rehabilitation after cardiovascular diseases, with special emphasis on developing countries. Report of a WHO expert committee. World Health Organ Tech Rep Ser 831 (1993) 1-122
50. Juniper E., Guyatt G., and Jaeschke R. How to develop and validate a new health-related quality of life instrument. In: Spilker B. (Ed). Quality of life and pharmacoeconomics in clinical trials. 2nd edition (1996), Lipppincott-Raven Publishers, Philadelphia 49-56
51. Scientific Advisory Committee. Assessing health status and quality-of-life instruments: attributes and review criteria. Qual Life Res 11 3 (2002) 193-205
52. Gliklich R.E., Goldsmith T.A., and Funk G.F. Are head and neck specific quality of life measures necessary?. Head Neck 19 6 (1997) 474-480
53. Pusic A., Liu J.C., Chen C.M., et al. A systematic review of patient-reported outcome measures in head and neck cancer surgery. Otolaryngol Head Neck Surg 136 4 (2007) 525-535
54. Bjordal K., and Kaasa S. Psychometric validation of the EORTC core quality of life questionnaire, 30-item version and a diagnosis-specific module for head and neck cancer patients. Acta Oncol 31 3 (1992) 311-321
55. Terrell J.E., Nanavati K.A., Esclamado R.M., et al. Head and neck cancer-specific quality of life: instrument validation. Arch Otolaryngol Head Neck Surg 123 10 (1997) 1125-1132
56. Funk G.F., Karnell L.H., Christensen A.J., et al. Comprehensive head and neck oncology health status assessment. Head Neck 25 (2003) 561-575
57. Ringash J., and Bezjak A. A structured review of quality of life instruments for head and neck cancer patients. Head Neck 23 3 (2001) 201-213
58. Cella D.F., Tulsky D.S., Gray G., et al. The Functional Assessment of Cancer Therapy Scale: development and validation of the general measure. J Clin Oncol 11 3 (1993) 570-579
59. List M.A., D'Antonio L.L., Cella D.F., et al. The Performance Status Scale for head and neck cancer patients and the Functional Assessment of Cancer Therapy-Head and Neck Scale. A study of utility and validity. Cancer 77 11 (1996) 2294-2301
60. Weymuller E.A., Alsarraf R., Yueh B., et al. Analysis of the performance characteristics of the University of Washington quality of life instrument and its modification (UW-QOL-R). Arch Otolaryngol Head Neck Surg 127 5 (2001) 489-493
61. Johnson D.J., Casey L., and Noriega B. A pilot study of patient quality of life during radiation therapy treatment. Qual Life Res 3 4 (1994) 267-272
62. Trotti A., Johnson D.J., Gwede C., et al. Development of a head and neck companion module for the Quality of Life-Radiation Therapy Instrument (QOL-RTI). Int J Radiat Oncol Biol Phys 42 2 (1998) 257-261
63. Browman G.P., Levine M.N., Hodson D.I., et al. The Head and Neck Radiotherapy questionnaire: a morbidity/quality-of-life instrument for clinical trials of radiation therapy in locally advanced head and neck cancer. J Clin Oncol 11 5 (1993) 863-872
64. Ringash J., O'Sullivan B., Bezjak A., et al. Interpreting clinically significant changes in patient-reported outcomes. Cancer 110 1 (2007) 196-202
65. Gotay C.C., Kawamoto C.T., Bottomley A., et al. The prognostic significance of patient-reported outcomes in cancer clinical trials. J Clin Oncol 26 8 (2008) 1355-1363
66. Karvonen-Gutierrez C.A., Ronis D.L., Fowler K.E., et al. Quality of life scores predict survival among patients with head and neck cancer. J Clin Oncol 26 16 (2008) 2754-2760
67. Ringash J., Lockwood G., O'Sullivan B., et al. Hyperfractionated, accelerated radiotherapy for locally advanced head and neck cancer: quality of life in a prospective phase I/II trial. Radiother Oncol 87 2 (2008) 181-187
68. Siddiqui F., Pajak T.F., Watkins-Bruner D., et al. Pretreatment quality of life predicts for locoregional control in head and neck cancer patients: a Radiation Therapy Oncology Group analysis. Int J Radiat Oncol Biol Phys 70 2 (2008) 353-360
69. Chandu A., Smith A.C., and Rogers S.N. Health-related quality of life in oral cancer: a review. J Oral Maxillofac Surg 64 3 (2006) 495-502
70. Nguyen N.P., Sallah S., Karlsson U., et al. Combined chemotherapy and radiation therapy for head and neck malignancies: quality of life issues. Cancer 94 4 (2002) 1131-1141
71. Mehanna H.M., and Morton R.P. Deterioration in quality-of-life of late (10-year) survivors of head and neck cancer. Clin Otolaryngol 31 3 (2006) 204-211
72. Hammerlid E., and Taft C. Health-related quality of life in long-term head and neck cancer survivors: a comparison with general population norms. Br J Cancer 84 2 (2001) 149-156
73. Dirix P., Nuyts S., and Van den Bogaert W. Radiation-induced xerostomia in patients with head and neck cancer: a literature review. Cancer 107 11 (2006) 2525-2534
74. Hamlet S., Faull J., Klein B., et al. Mastication and swallowing in patients with postirradiation xerostomia. Int J Radiat Oncol Biol Phys 37 4 (1997) 789-796
75. Rhodus N.L., Moller K., Colby S., et al. Articulatory speech performance in patients with salivary gland dysfunction: a pilot study. Quintessence Int 26 11 (1995) 805-810
76. Roesink J.M., Schipper M., Busschers W., et al. A comparison of mean parotid gland dose with measures of parotid gland function after radiotherapy for head-and-neck cancer: implications for future trials. Int J Radiat Oncol Biol Phys 63 4 (2005) 1006-1009
77. LENT-SOMA tables. Radiother Oncol 35 (1995) 17-60
78. Cox J.D., Stetz J., and Pajak T.F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31 5 (1995) 1341-1346
79. Trotti A., Colevas A.D., Setser A., et al. CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 13 3 (2003) 176-181
80. Johnson J.T., Ferretti G.A., Nethery W.J., et al. Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer. N Engl J Med 329 6 (1993) 390-395
81. Eisbruch A., Kim H.M., Terrell J.E., et al. Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer. Int J Radiat Oncol Biol Phys 50 3 (2001) 695-704
82. Ringash J., Warde P., Lockwood G., et al. Postradiotherapy quality of life for head-and-neck cancer patients is independent of xerostomia. Int J Radiat Oncol Biol Phys 61 5 (2005) 1403-1407
83. Sprangers M.A., and Schwartz C.E. Integrating response shift into health-related quality of life research: a theoretical model. Soc Sci Med 48 11 (1999) 1507-1515
84. Kam M.K., Leung S.F., Zee B., et al. Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients. J Clin Oncol 25 31 (2007) 4873-4879
85. Pow E.H., Kwong D.L., McMillan A.S., et al. Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial. Int J Radiat Oncol Biol Phys 66 4 (2006) 981-991
86. Jellema A.P., Slotman B.J., Doornaert P., et al. Unilateral versus bilateral irradiation in squamous cell head and neck cancer in relation to patient-rated xerostomia and sticky saliva. Radiother Oncol 85 1 (2007) 83-89
87. Yao M., Karnell L.H., Funk G.F., et al. Health-related quality-of-life outcomes following IMRT versus conventional radiotherapy for oropharyngeal squamous cell carcinoma. Int J Radiat Oncol Biol Phys 69 5 (2007) 1354-1360
88. Chambers M.S., Garden A.S., Rosenthal D., et al. Intensity-modulated radiotherapy: is xerostomia still prevalent?. Curr Oncol Rep 7 2 (2005) 131-136
89. Cannon D.M., and Lee N.Y. Recurrence in region of spared parotid gland after definitive intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 70 3 (2008) 660-665
90. Brizel D.M., Wasserman T.H., Henke M., et al. Phase III randomized trial of amifostine as a radioprotector in head and neck cancer. J Clin Oncol 18 19 (2000) 3339-3345
91. Wasserman T.H., Brizel D.M., Henke M., et al. Influence of intravenous amifostine on xerostomia, tumor control, and survival after radiotherapy for head-and-neck cancer: 2-year follow-up of a prospective, randomized, phase III trial. Int J Radiat Oncol Biol Phys 63 4 (2005) 985-990
92. Jha N., Seikaly H., McGaw T., et al. Submandibular salivary gland transfer prevents radiation-induced xerostomia. Int J Radiat Oncol Biol Phys 46 1 (2000) 7-11
93. Seikaly H., Jha N., Harris J.R., et al. Long-term outcomes of submandibular gland transfer for prevention of postradiation xerostomia. Arch Otolaryngol Head Neck Surg 130 8 (2004) 956-961
94. Jha N., Seikaly H., Harris J., et al. Prevention of radiation induced xerostomia by surgical transfer of submandibular salivary gland into the submental space. Radiother Oncol 66 3 (2003) 283-289
95. Saibishkumar E.P., Jha N., Scrimger R.A., et al. Sparing the parotid glands and surgically transferred submandibular gland with helical tomotherapy in post-operative radiation of head and neck cancer: a planning study. Radiother Oncol 85 1 (2007) 98-104
96. Karnell L.H., Funk G.F., and Hoffman H.T. Assessing head and neck cancer patient outcome domains. Head Neck 22 1 (2000) 6-11
97. Lewin J.S. Speech and swallowing following treatment for oral cancer. In: Werning J.W. (Ed). Oral cancer (2007), Thieme Medical Publishers, New York 304-308
98. Perry A.R., and Shaw M.A. Evaluation of functional outcomes (speech, swallowing and voice) in patients attending speech pathology after head and neck cancer treatment(s): development of a multi-centre database. J Laryngol Otol 114 8 (2000) 605-615
99. Pauloski B.R., Rademaker A.W., Logemann J.A., et al. Pretreatment swallowing function in patients with head and neck cancer. Head Neck 22 5 (2000) 474-482
100. Ward E.C., Bishop B., Frisby J., et al. Swallowing outcomes following laryngectomy and pharyngolaryngectomy. Arch Otolaryngol Head Neck Surg 128 2 (2002) 181-186
101. Rieger J.M., Zalmanowitz J.G., and Wolfaardt J.F. Functional outcomes after organ preservation treatment in head and neck cancer: a critical review of the literature. Int J Oral Maxillofac Surg 35 7 (2006) 581-587
102. Lewin J.S. Dysphagia after chemoradiation: prevention and treatment. Int J Radiat Oncol Biol Phys 69 2 Suppl (2007) S86-S87
103. Logemann J.A., Pauloski B.R., Rademaker A.W., et al. Xerostomia: 12-month changes in saliva production and its relationship to perception and performance of swallow function, oral intake, and diet after chemoradiation. Head Neck 25 6 (2003) 432-437
104. Nguyen N.P., Frank C., Moltz C.C., et al. Aspiration rate following chemoradiation for head and neck cancer: an underreported occurrence. Radiother Oncol 80 3 (2006) 302-306
105. Rademaker A.W., Vonesh E.F., Logemann J.A., et al. Eating ability in head and neck cancer patients after treatment with chemoradiation: a 12-month follow-up study accounting for dropout. Head Neck 25 12 (2003) 1034-1041
106. Frowen J.J., and Perry A.R. Swallowing outcomes after radiotherapy for head and neck cancer: a systematic review. Head Neck 28 10 (2006) 932-944
107. Blood G.W. Development and assessment of a scale addressing communication needs of patients with laryngectomies. Am J Speech Lang Pathol 2 3 (1993) 82-90
108. Jacobson B.H., Johnson A., Grywalski C., et al. The Voice Handicap Index (VHI): development and validation. Am J Speech Lang Pathol 6 3 (1997) 66-70
109. Chen A.Y., Frankowski R., Bishop-Leone J., et al. The development and validation of a dysphagia-specific quality-of-life questionnaire for patients with head and neck cancer: the M.D. Anderson dysphagia inventory. Arch Otolaryngol Head Neck Surg 127 7 (2001) 870-876
110. McHorney C.A., Bricker D.E., Kramer A.E., et al. The SWAL-QOL outcomes tool for oropharyngeal dysphagia in adults: I. Conceptual foundation and item development. [see comments]. Dysphagia 15 3 (2000) 115-121
111. McHorney C.A., Bricker D.E., Robbins J., et al. The SWAL-QOL outcomes tool for oropharyngeal dysphagia in adults: II. Item reduction and preliminary scaling. [see comments]. Dysphagia 15 3 (2000) 122-133
112. McHorney C.A., Robbins J., Lomax K., et al. The SWAL-QOL and SWAL-CARE outcomes tool for oropharyngeal dysphagia in adults: III. Documentation of reliability and validity. Dysphagia 17 2 (2002) 97-114
113. List M.A., Ritter-Sterr C., and Lansky S.B. A performance status scale for head and neck cancer patients. Cancer 66 3 (1990) 564-569
114. Martin-Harris B., Michel Y., Brodsky M.B., et al. Standardized MBS assessment of swallowing impairment. [abstract]. Dysphagia 22 (2007) 355-368
115. Nagi S.Z. Disability concepts revisited: implications for prevention. In: Pope A., and Tarlov A. (Eds). Diability in America: toward a national agenda for prevention (1991), National Academy Press, Washington, DC 309-327
116. Jette A.M., and Badley E. Conceptual issues in the measurement of work disability. In: Wunderlich G.S., Rice D.P., and Amado N.L. (Eds). The dynamics of disability: measuring and monitoring disability for social security program (2002), National Academies Press, Washington, DC 183-210
117. Logemann J.A., Pauloski B.R., Rademaker A.W., et al. Super-supraglottic swallow in irradiated head and neck cancer patients. Head Neck 19 6 (1997) 535-540
118. Graff P., Lapeyre M., Desandes E., et al. Impact of intensity-modulated radiotherapy on health-related quality of life for head and neck cancer patients: matched-pair comparison with conventional radiotherapy. Int J Radiat Oncol Biol Phys 67 5 (2007) 1309-1317